David Krempa, Chief Business Officer at Eton Pharmaceuticals, Inc. (ETON), sold 61,200 shares at $14.73 ($908K) on 2025-06-16, disclosed to the SEC on 2025-06-16.
Open-market sale of $908k ETON by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.92 | 16,977 | $253K | 27.9% |
| 2 | $14.92 | 16,977 | $253K | 27.9% |
| 3 | $14.77 | 6,800 | $100K | 11.1% |
| 4 | $14.73 | 10,223 | $151K | 16.6% |
| 5 | $14.73 | 10,223 | $151K | 16.6% |
| Total | $14.84 avg | 61,200 |
| $908K |
| 100% |
| Filing → |
| ETON | SELL | 2026-05-27 | $3.2M | — | Filing → |